Ramaswamy GOVINDAN
Chinese Journal of Lung Cancer 2010;13(4):363-369
Carcinoma, Non-Small-Cell Lung ; drug therapy ; metabolism ; Humans ; Lung Neoplasms ; drug therapy ; metabolism ; Models, Biological ; Protein Kinase Inhibitors ; therapeutic use ; Receptor, Epidermal Growth Factor ; antagonists & inhibitors ; Receptor, ErbB-2 ; antagonists & inhibitors